CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Ivosidenib

艾伏尼布 杂质对照品Ivosidenib Impurities

39 个杂质条目39 impurity entries

本页汇总 艾伏尼布 的 39 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 39 impurity reference standards of Ivosidenib. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 艾伏尼布(Ivosidenib)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesLC and LC-MS/MS Analysis for Characterization of Novel Degradation Products of Ivosidenib: Exploration of Degradation Pathways and In Silico Predictions
    ACS omega · 2025 · Foudah AI et al.  ·  PMID 39926494  ·  DOI
  2. 分析方法Analytical MethodsValidated HPLC method for simultaneous quantification of mutant IDH1/2 inhibitors (enasidenib, ivosidenib and vorasidenib) in mouse plasma: Application to a pharmacokinetic study
    Biomedical chromatography : BMC · 2019 · Zakkula A et al.  ·  PMID 31325170  ·  DOI
  3. 分析方法Analytical MethodsA Simple HPLC-UV Method for Ivosidenib Determination in Human Plasma
    Journal of chromatographic science · 2024 · Gando Y, Yasu T  ·  PMID 37873880  ·  DOI
  4. 分析方法Analytical MethodsInhibitory effects of voriconazole, itraconazole and fluconazole on the pharmacokinetic profiles of ivosidenib in rats by UHPLC-MS/MS
    Journal of pharmaceutical and biomedical analysis · 2020 · Xie S et al.  ·  PMID 32417565  ·  DOI
  5. 分析方法Analytical MethodsValidated LC-ESI-MS/MS method for the determination of ivosidenib in 10 μL mice plasma: application to a pharmacokinetic study
    ADMET & DMPK · 2019 · Dittakavi S et al.  ·  PMID 35350545  ·  DOI

艾伏尼布 —— 原料药与杂质对照品Ivosidenib — drug substance & impurities

共 40 个条目(含原料药本体)40 items incl. the drug substance
Ivosidenib structure
原料药 APIAPI
艾伏尼布Ivosidenib
Ivosidenib
CAS No.1448347-49-6
Chemical FormulaC28H22ClF3N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Ivosidenib Impurity 1 structure
1
艾伏尼布杂质1Ivosidenib Impurity 1
Ivosidenib Impurity 1
CAS No.2408269-66-7
Chemical FormulaC28H22ClF3N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Ivosidenib Impurity 2 structure
2
艾伏尼布杂质2Ivosidenib Impurity 2
Ivosidenib Impurity 2
CAS No.2070009-31-1
Chemical FormulaC28H22ClF3N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Ivosidenib Impurity 3 structure
3
艾伏尼布杂质3Ivosidenib Impurity 3
Ivosidenib Impurity 3
CAS No.1448346-63-1
Chemical FormulaC28H22ClF3N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Ivosidenib Impurity 4 structure
4
艾伏尼布杂质4Ivosidenib Impurity 4
Ivosidenib Impurity 4
CAS No.2408269-65-6
Chemical FormulaC28H22ClF3N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Ivosidenib Impurity 5 structure
5
艾伏尼布杂质5Ivosidenib Impurity 5
Ivosidenib Impurity 5
CAS No.2408269-72-5
Chemical FormulaC28H21Cl2F3N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Ivosidenib Impurity 6 structure
6
艾伏尼布杂质6Ivosidenib Impurity 6
Ivosidenib Impurity 6
CAS No.2408269-71-4
Chemical FormulaC28H21Cl2F3N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Ivosidenib Impurity 7 structure
7
艾伏尼布杂质7Ivosidenib Impurity 7
Ivosidenib Impurity 7
CAS No.2408269-70-3
Chemical FormulaC28H21Cl2F3N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Ivosidenib Impurity 8 structure
8
艾伏尼布杂质8Ivosidenib Impurity 8
Ivosidenib Impurity 8
CAS No.2504148-06-3
Chemical FormulaC28H22ClF3N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Ivosidenib Impurity 9 structure
9
艾伏尼布杂质9Ivosidenib Impurity 9
Ivosidenib Impurity 9
CAS No.2504147-85-5
Chemical FormulaC28H22ClF3N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Ivosidenib Impurity 10 structure
10
艾伏尼布杂质10Ivosidenib Impurity 10
Ivosidenib Impurity 10
CAS No.2772410-36-1
Chemical FormulaC29H24ClF3N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Ivosidenib Impurity 11 structure
11
艾伏尼布杂质11Ivosidenib Impurity 11
Ivosidenib Impurity 11
CAS No.2408269-73-6
Chemical FormulaC28H22ClF3N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Ivosidenib Impurity 12 structure
12
艾伏尼布杂质12Ivosidenib Impurity 12
Ivosidenib Impurity 12
CAS No.1646861-37-1
Chemical FormulaC28H22ClF3N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Ivosidenib Impurity 13 structure
13
艾伏尼布杂质13Ivosidenib Impurity 13
Ivosidenib Impurity 13
CAS No.1448347-66-7
Chemical FormulaC30H26ClF3N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Ivosidenib Impurity 14 structure
14
艾伏尼布杂质14Ivosidenib Impurity 14
Ivosidenib Impurity 14
CAS No.1448347-20-3
Chemical FormulaC28H22F4N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Ivosidenib Impurity 15 structure
15
艾伏尼布杂质15Ivosidenib Impurity 15
Ivosidenib Impurity 15
CAS No.1448346-06-2
Chemical FormulaC29H23ClF3N5O3
Purity>95%询价On request
10mg25mg50mg100mg
Ivosidenib Impurity 16 structure
16
艾伏尼布杂质16Ivosidenib Impurity 16
Ivosidenib Impurity 16
CAS No.1448346-05-1
Chemical FormulaC29H23ClF3N5O3
Purity>95%询价On request
10mg25mg50mg100mg
Ivosidenib Impurity 17 structure
17
艾伏尼布杂质17Ivosidenib Impurity 17
Ivosidenib Impurity 17
CAS No.2886739-07-5
Chemical FormulaC28H22BrClF2N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Ivosidenib Impurity 18 structure
18
艾伏尼布杂质18Ivosidenib Impurity 18
Ivosidenib Impurity 18
CAS No.1448347-60-1
Chemical FormulaC29H23ClF3N5O3
Purity>95%询价On request
10mg25mg50mg100mg
Ivosidenib Impurity 19 structure
19
艾伏尼布杂质19Ivosidenib Impurity 19
Ivosidenib Impurity 19
CAS No.2128261-21-0
Chemical FormulaC28H23ClF2N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Ivosidenib Impurity 20 structure
20
艾伏尼布杂质20Ivosidenib Impurity 20
Ivosidenib Impurity 20
CAS No.1448346-41-5
Chemical FormulaC29H23ClF3N5O3
Purity>95%询价On request
10mg25mg50mg100mg
Ivosidenib Impurity 21 structure
21
艾伏尼布杂质21Ivosidenib Impurity 21
Ivosidenib Impurity 21
CAS No.1448346-16-4
Chemical FormulaC29H23ClF3N5O3
Purity>95%询价On request
10mg25mg50mg100mg
Ivosidenib Impurity 22 structure
22
艾伏尼布杂质22Ivosidenib Impurity 22
Ivosidenib Impurity 22
CAS No.1448346-15-3
Chemical FormulaC29H23ClF3N5O3
Purity>95%询价On request
10mg25mg50mg100mg
Ivosidenib Impurity 23 structure
23
艾伏尼布杂质23Ivosidenib Impurity 23
Ivosidenib Impurity 23
CAS No.1448347-19-0
Chemical FormulaC28H23F3N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Ivosidenib Impurity 24 structure
24
艾伏尼布杂质24Ivosidenib Impurity 24
Ivosidenib Impurity 24
CAS No.2408269-64-5
Chemical FormulaC28H24ClF3N6O4
Purity>95%询价On request
10mg25mg50mg100mg
Ivosidenib Impurity 25 structure
25
艾伏尼布杂质25Ivosidenib Impurity 25
Ivosidenib Impurity 25
CAS No.1448345-96-7
Chemical FormulaC29H26ClF3N4O3
Purity>95%询价On request
10mg25mg50mg100mg
Ivosidenib Impurity 26 structure
26
艾伏尼布杂质26Ivosidenib Impurity 26
Ivosidenib Impurity 26
CAS No.1448345-87-6
Chemical FormulaC27H23ClF3N5O3
Purity>95%询价On request
10mg25mg50mg100mg
Ivosidenib Impurity 27 structure
27
艾伏尼布杂质27Ivosidenib Impurity 27
Ivosidenib Impurity 27
CAS No.1646862-26-1
Chemical FormulaC34H26ClF3N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Ivosidenib Impurity 28 structure
28
艾伏尼布杂质28Ivosidenib Impurity 28
Ivosidenib Impurity 28
CAS No.1646861-42-8
Chemical FormulaC34H26ClF3N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Ivosidenib Impurity 29 structure
29
艾伏尼布杂质29Ivosidenib Impurity 29
Ivosidenib Impurity 29
CAS No.1646861-40-6
Chemical FormulaC34H26ClF3N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Ivosidenib Impurity 30 structure
30
艾伏尼布杂质30Ivosidenib Impurity 30
Ivosidenib Impurity 30
CAS No.1448347-71-4
Chemical FormulaC28H21ClF4N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Ivosidenib Impurity 31 structure
31
艾伏尼布杂质31Ivosidenib Impurity 31
Ivosidenib Impurity 31
CAS No.1448347-50-9
Chemical FormulaC30H22ClF3N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Ivosidenib Impurity 32 structure
32
艾伏尼布杂质32Ivosidenib Impurity 32
Ivosidenib Impurity 32
CAS No.1448346-43-7
Chemical FormulaC29H22ClF4N5O3
Purity>95%询价On request
10mg25mg50mg100mg
Ivosidenib Impurity 33 structure
33
艾伏尼布杂质33Ivosidenib Impurity 33
Ivosidenib Impurity 33
CAS No.1448347-61-2
Chemical FormulaC29H22ClF4N5O3
Purity>95%询价On request
10mg25mg50mg100mg
Ivosidenib Impurity 34 structure
34
艾伏尼布杂质34Ivosidenib Impurity 34
Ivosidenib Impurity 34
CAS No.2772910-48-0
Chemical FormulaC30H25ClF3N5O3
Purity>95%询价On request
10mg25mg50mg100mg
Ivosidenib Impurity 35 structure
35
艾伏尼布杂质35Ivosidenib Impurity 35
Ivosidenib Impurity 35
CAS No.1646861-47-3
Chemical FormulaC34H26ClF3N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Ivosidenib Impurity 36 structure
36
艾伏尼布杂质36Ivosidenib Impurity 36
Ivosidenib Impurity 36
CAS No.1646861-46-2
Chemical FormulaC34H26ClF3N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Ivosidenib Impurity 37 structure
37
艾伏尼布杂质37Ivosidenib Impurity 37
Ivosidenib Impurity 37
CAS No.1646861-44-0
Chemical FormulaC34H26ClF3N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Ivosidenib Impurity 38 structure
38
艾伏尼布杂质38Ivosidenib Impurity 38
Ivosidenib Impurity 38
CAS No.1448347-70-3
Chemical FormulaC29H22ClF4N5O3
Purity>95%询价On request
10mg25mg50mg100mg
Ivosidenib Impurity 39 structure
39
艾伏尼布杂质39Ivosidenib Impurity 39
Ivosidenib Impurity 39
CAS No.1355328-31-2
Chemical FormulaC5H5F2N
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

For formulation & analytical R&D

艾伏尼布 杂质谱研究要点Ivosidenib — impurity profiling notes

下面这些是拿到 艾伏尼布 的 40 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 40 impurity entries for Ivosidenib, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances